PEXELIZUMAB
UNII CHZ6OLQ3UU

Substance Identification & Data

This profile provides standardized clinical and technical data for Pexelizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CHZ6OLQ3UU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 219685-93-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
CHZ6OLQ3UU
CAS Registry Number
219685-93-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PEXELIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8153
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
LL-71
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pexelizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEXELIZUMAB

Common Names & Synonyms

PEXELIZUMAB [INN]
PEXELIZUMAB [MART.]
PEXELIZUMAB [MI]
PEXELIZUMAB [USAN]
PEXELIZUMAB [WHO-DD]

Technical Codes

5G1.1-SC
H5G1.1 SCFV
H-5G1.1 SCFV
H5G1.1 SCFV (CDR)